RGDyK downregulated PD-L1 expression by targeting β3-int, promoting PD-L1 ubiquitination, while ZnPP-mediated PDT-generated ROS, thus promoting the release of tumor antigens (Fig. 8E). This evidence concerns the gene CD274 and neoplasm.